The inflammatory bowel diseases (IBDs) are contemporary conditions of industrialized
societies. The prevalence of IBD continues to increase steadily in Western countries, and …

Inflammatory bowel disease (IBD) is a complex set of diseases that lead to chronic
inflammation in the gastrointestinal tract. Although the etiology of IBD is not fully understood …

We demonstrated the metabolic benefits of Parabacteroides distasonis (PD) on decreasing
weight gain, hyperglycemia, and hepatic steatosis in ob/ob and high-fat diet (HFD)-fed mice …

Objective A close relationship between gut microbiota and some chronic liver disorders has
recently been described. Herein, we systematically performed a comparative analysis of the …

Objective The significance of the liver-microbiome axis has been increasingly recognised as
a major modulator of autoimmunity. The aim of this study was to take advantage of a large …

Objective Gut microbiota could influence gut, as well as hepatic and biliary immune
responses. We therefore thoroughly characterised the gut microbiota in primary sclerosing …

Objective Pre-eclampsia (PE) is one of the malignant metabolic diseases that complicate
pregnancy. Gut dysbiosis has been identified for causing metabolic diseases, but the role of …

Dysbiosis is a hallmark of inflammatory bowel disease (IBD), but it is unclear which specific
intestinal bacteria predispose to and which protect from IBD and how they are regulated …

Background: The pathogenesis of inflammatory bowel diseases (IBD) involves complex
interactions between the microbiome and the immune system. We evaluated the association …

Gut microbiota dysbiosis is a common feature in colorectal cancer (CRC) and inflammatory
bowel diseases (IBD). Adoption of the Mediterranean diet (MD) has been proposed as a …